BioSpace News Archive

Determination finds that Agendia’s MammaPrint® Breast Cancer Risk of Recurrence test improves net health outcome for patients and positions the test well for further adoption by health insurance plans in the U.S.

Ascension Wisconsin, part of Ascension, the nation’s leading nonprofit and Catholic healthcare system, and Emerus Holdings Inc., the nation’s first and largest operator of neighborhood hospitals, today announced a new partnership.

- National Dialysis Accreditation Commission, LLC (NDAC), an Accreditation Organization (AO) specializing in the dialysis industry, has received approval of deemed status from the Centers for Medicare and Medicaid Services (CMS). Visit the NDAC website at www.ndacommission.com.

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Ohr Pharmaceutical, Inc. (“OHRP” or the “Company”) (NASDAQ: OHRP) in connection with the proposed acquisition of the Company by NeuBase Therapeutics, Inc.

PharmaCielo Ltd. (“PharmaCielo” or the “Company”), the Canadian parent of Colombia’s premier cultivator and producer of medicinal-grade cannabis oil (PharmaCielo Colombia Holdings S.A.S.), today provided a corporate progress update in preparation for its public listing on the TSXV under the ticker PCLO (TSXV:PCLO), on or about January 18, 2019.

Solidarity HealthShare is pleased to announce it is a major sponsor of the 46th annual March For Life, the world’s largest annual human rights demonstration to be held in Washington, DC January 18, 2019.

First quarter net revenues of $7.5 million reflecting 6.6% year over year growth

Veracyte, Inc. today announced that Bonnie H. Anderson, chairman and chief executive officer, is scheduled to present at the 21st Annual Needham Growth Conference in New York City on Tuesday, January 15, 2019 at 8:40 a.m. EST (5:40 a.m. PST).

HERCULES Phase 3 trial met its primary endpoint, demonstrating that treatment with Cablivi resulted in a significantly faster time to platelet count response in patients with acquired thrombotic thrombocytopenic purpura (aTTP) when administered in conjunction with plasma exchange and immunosuppression

Grant will provide much-needed training in February and March for underserved communities threatened by typhoons, tropical storms, floods and other natural disasters